The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis

作者：Xin He, Xiantao Zhang, Bolin Wu, Jieyi Deng, Yongli Zhang, Yongli Zhang, Airu Zhu, Yaochang Yuan, Yingtong Lin, Achun Chen, Jinzhu Feng, Xiumei Wang, Shijian Wu, Yingying Liu, Jie Liu, Yalin Wang, Chaofeng Liang, Chaofeng Liang, Quyu Yuan, Yu Liang, Qiannan Fang, Zhihui Xi, Wenjie Li, Liting Liang, Zhenglai Zhang, Hui Tang, Yi Peng, Changwen Ke, Xiancai Ma, Weibin Cai, Ting Pan, Bingfeng Liu, Kai Deng, Jun Chen, Jincun Zhao, Xuepeng Wei, Ran Chen, Hui Zhang, Yiwen Zhang, Hui Zhang · 发表于：Nature Immunology · 年份：2024 · DOI：10.1038/s41590-024-01776-2 · 被引用次数：17 · 研究领域：SARS-CoV-2 and COVID-19 Research、Immunotherapy and Immune Responses、Complement system in diseases